What's happening
This bill ensures ovarian cancer survivors in New York have unrestricted access to genetic testing and tumor profiling for related mutations.
Why it matters
Removes insurance or policy-based barriers. that might prevent ovarian cancer survivors from accessing crucial genetic and tumor testing, regardless of how often they need it.
Targets high-risk mutations. (like BRCA1, BRCA2, and those associated with Lynch syndrome), ensuring that survivors can identify inherited or acquired genetic risks that could affect their future treatment and their families’ health decisions.
Empowers healthcare providers. to order additional medically necessary mutation tests beyond the listed ones, allowing for personalized care based on evolving medical knowledge or patient-specific needs.
May lead to earlier interventions. or tailored therapies for survivors and their relatives, potentially improving outcomes and offering peace of mind through comprehensive genetic information.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Guarantee Survivor Cancer Screenings
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Guarantee Cancer Survivor Screenings
In Assembly Committee · Health · Sponsor Roxanne J. Persaud
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
7161
2023-2024 Regular Sessions
IN ASSEMBLY
May 11, 2023
Introduced by M. of A. SOLAGES -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to ensuring ovarian cancer survivors have the right to access screenings for health conditions
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The public health law is amended by adding a new section 2404-e to read as follows:
§ 2404-e. Ovarian cancer; right to screenings. No person with a personal history of ovarian cancer shall be denied genetic testing or genomic tumor profiling for inherited germline mutations and acquired somatic mutations, respectively. In general, such testing shall not be subject to frequency caps or other limitations and shall include, but not be limited to:
(a) genetic mutations in BRCA1 and BRCA2 genes;
(b) genetic mutations associated with Lynch syndrome;
(c) rearrangement analysis of all coding exons associated with ovarian cancer; and
(d) additional mutations if medically necessary and appropriate, as determined by the health care professional treating the individual.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD02538-01-3
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.